Informações:
Falhas:
ID
31906
Descrição
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT00996606
Link
https://clinicaltrials.gov/show/NCT00996606
Palavras-chave
Versões (1)
- 08/10/2018 08/10/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
8 de outubro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Rheumatoid Arthritis NCT00996606
Eligibility Rheumatoid Arthritis NCT00996606
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00996606
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients, >/=18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid arthritis moderate Duration | Rheumatoid Arthritis Severe Duration
Item
moderate to severe active rheumatoid arthritis of >/=6 months duration
boolean
C2368567 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
DAS in rheumatoid arthritis
Item
das >/=3.2
boolean
C2732410 (UMLS CUI [1])
DMARDs Dose Stable | Response Inadequate
Item
inadequate response to a stable dose of dmards
boolean
C0242708 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Adrenal Cortex Hormones Oral Dose Stable
Item
patients receiving oral corticosteroids must have been at stable dose on >/=25 days in the 28 days prior to first study treatment
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis
Item
rheumatic autoimmune disease other than ra
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Joint disease | Exception Rheumatoid Arthritis
Item
history of or current joint disease other than ra
boolean
C0022408 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Biological agent
Item
previous treatment with a biologic
boolean
C0005515 (UMLS CUI [1])
Intraarticular injection of corticosteroids | Adrenal Cortex Hormones Parenteral
Item
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
boolean
C2064783 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
C0001617 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
B-cell depletion therapy
Item
previous treatment with any cell-depleting therapies
boolean
C1171324 (UMLS CUI [1])
Rheumatoid Arthritis Functional Status Class
Item
functional class iv (acr)
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])